Anika Therapeutics (ANIK) Asset Utilization Ratio (2011 - 2026)

Anika Therapeutics (ANIK) has 16 years of Asset Utilization Ratio data on file, last reported at 0.63 in Q1 2026.

• Asset Utilization Ratio for Q1 2026 came in at 0.63, up 5.69% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.63 (up 5.69% YoY), and the FY2025 annual result was 0.57, up 13.33% from the prior year.
• Asset Utilization Ratio improved to 0.63 in Q1 2026 per ANIK's latest filing, from 0.59 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.63 in Q1 2026 and troughed at 0.33 in Q4 2022.
• A 5-year average of 0.46 and a median of 0.43 in 2022 frame the typical range for Asset Utilization Ratio.
• The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio decreased 23.22% in 2023, then surged 71.04% in 2025.
• A 5-year view of Asset Utilization Ratio shows it stood at 0.33 in 2022, then grew by 23.5% to 0.4 in 2023, then jumped by 36.91% to 0.55 in 2024, then increased by 7.58% to 0.59 in 2025, then gained by 5.85% to 0.63 in 2026.
• Business Quant data shows ANIK's Asset Utilization Ratio at 0.63 in Q1 2026, 0.59 in Q4 2025, and 0.6 in Q3 2025.